Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma
Wenli Mao,1,* Heng Yin,2,* Wenya Chen,1,* Tingxiu Zhao,1 Shaofeng Wu,3 He Jin,1 Biaoyan Du,1 Yuhui Tan,2 Ren Zhang,2,3 Yanli He1,3 1Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, People’s Republic o...
Main Authors: | Mao W, Yin H, Chen W, Zhao T, Wu S, Jin H, Du B, Tan Y, Zhang R, He Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/network-pharmacology-and-experimental-evidence-reveal-dioscin-suppress-peer-reviewed-article-DDDT |
Similar Items
-
Dioscin ameliorates doxorubicin‐induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1‐mediated Akt/mTOR signaling pathway
by: Ling Yuan, et al.
Published: (2023-10-01) -
Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling
by: Zhang C, et al.
Published: (2023-08-01) -
Dioscin: Therapeutic potential for diabetes and complications
by: Haoyang Gao, et al.
Published: (2024-01-01) -
Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia
by: Zhang L, et al.
Published: (2022-09-01) -
Neuroprotective Effect of Dioscin on the Aging Brain
by: Yan Qi, et al.
Published: (2019-03-01)